SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: DewDiligence_on_SI who wrote (3262)3/23/2021 5:15:14 PM
From: A.J. Mullen  Read Replies (1) | Respond to of 3557
 
That link discusses a trial started in September for an IV administered drug. The Bloomberg piece is about a pill "likely given twice a day for five days." They plan on moving to Phase II/III "early in the second quarter." - Next month??



To: DewDiligence_on_SI who wrote (3262)3/24/2021 6:50:24 PM
From: CuttingEdge Bio  Read Replies (1) | Respond to of 3557
 
Do you believe the fact that it's old and originally for SARS has important bearing on whether or not it will work for Covid? Or just presenting the factoid?